https://www.selleckchem.com/pr....oducts/nazartinib-eg
Previous studies have investigated patients' treatment goals before starting a treatment for metastatic lung cancer. Data on the evaluation of treatment goals are lacking. To determine if patients with metastatic lung cancer and their oncologists perceive the treatment goals they defined at the start of systemic treatment as achieved after treatment and if in hindsight they believe it was the right decision to start systemic therapy. A prospective multicenter study in 6 hospitals across the Netherlands between 2016 and
Like
Comment
Share
